Metherall Jessica P, Corner Philip A, McCabe James F, Probert Michael R, Hall Michael J
Chemistry, School of Natural and Environmental Sciences, Newcastle University Newcastle upon Tyne UK
Early Product Development & Manufacturing, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Macclesfield UK.
Chem Sci. 2025 Apr 22. doi: 10.1039/d4sc07556k.
Co-crystals are composed of two or more chemically inequivalent molecular species, excluding solvents, generally in a stoichiometric ratio. Co-crystals are particularly important in pharmaceutical development, where a suitable co-crystal can significantly improve the physiochemical and pharmacokinetic properties of an active pharmaceutical ingredient. However, co-crystal discovery remains both practically challenging and resource intensive, requiring the extensive searching of complex experimental space. Herein, we demonstrate a high-throughput (HTP) nanoscale co-crystallisation method for the rapid screening of large areas of co-crystallisation space with minimal sample requirements, based on Encapsulated Nanodroplet Crystallisation (ENaCt). HTP co-crystallisation screening by ENaCt allowed rapid access to all 18 possible binary co-crystal combinations of 3 small molecules and 6 co-formers (A/B), through the use of 3456 individual experiments exploring solvent, encapsulating oil and stoichiometry, including 10 novel binary co-crystal structures elucidated by single crystal X-ray diffraction (SCXRD). Higher-order co-crystal (HOC) discovery, accessing co-crystals containing three or more molecules, is one of the most challenging co-crystal research areas, due to the highly complex experimental landscape that must be navigated. Herein, we further exemplify the power of ENaCt co-crystallisation by application to HOC discovery. HTP ENaCt co-crystallisation screening of three component (A/B/C) and four component (A/B/C/D) combinations gave ready access to both ternary and quaternary HOCs, each containing three or four different molecular species respectively. In total, 13 056 individual ENaCt experiments are presented resulting in 54 co-crystal structures by SCXRD, including 17 novel binary co-crystals, 8 novel ternary co-crystals and 4 novel quaternary co-crystals. ENaCt co-crystallisation is thus demonstrated to be a highly impactful and efficient tool in the search for small molecule co-crystals, through the employment of parallelised HTP nanoscale experimental workflows.
共晶体由两种或更多种化学上不等价的分子物种组成,不包括溶剂,通常呈化学计量比。共晶体在药物开发中尤为重要,合适的共晶体可以显著改善活性药物成分的物理化学和药代动力学性质。然而,共晶体的发现实际上仍然具有挑战性且资源密集,需要广泛搜索复杂的实验空间。在此,我们展示了一种高通量(HTP)纳米级共结晶方法,基于包封纳米液滴结晶(ENaCt),以最少的样品需求快速筛选大面积的共结晶空间。通过ENaCt进行的HTP共结晶筛选,通过使用3456个探索溶剂、包封油和化学计量的单独实验,能够快速获得3种小分子和6种共形成物(A/B)的所有18种可能的二元共晶体组合,其中包括通过单晶X射线衍射(SCXRD)阐明的10种新型二元共晶体结构。高阶共晶体(HOC)的发现,即获得包含三个或更多分子的共晶体,是最具挑战性的共晶体研究领域之一,因为必须应对高度复杂的实验情况。在此,我们通过将其应用于HOC发现进一步例证了ENaCt共结晶的强大功能。对三种成分(A/B/C)和四种成分(A/B/C/D)组合进行的HTP ENaCt共结晶筛选,使得能够轻松获得三元和四元HOC,它们分别包含三种或四种不同的分子物种。总共展示了13056个单独的ENaCt实验,通过SCXRD得到了54种共晶体结构,包括17种新型二元共晶体、8种新型三元共晶体和4种新型四元共晶体。因此,通过采用并行化的HTP纳米级实验工作流程,ENaCt共结晶被证明是寻找小分子共晶体的一种极具影响力和高效的工具。